Retrospective Study
Copyright ©The Author(s) 2023.
World J Clin Cases. Nov 6, 2023; 11(31): 7543-7552
Published online Nov 6, 2023. doi: 10.12998/wjcc.v11.i31.7543
Table 1 Univariate analysis of the risk factors for deep vein thrombosis
Risk factorsNo (%) of DVT (n = 135)No (%) of No-DVT (n = 148)Univariate

HR (95%CI)
P value
Gender (male)52 (38.5)74 (50.0)0.627 (0.390-1.006)0.053
Age (yr)NANA1.072 (1.048-1.097)< 0.001
BMI (kg/m2)NANA0.988 (0.927-1.054)0.718
Smoking history31 (23.0)31 (20.9)1.125 (0.640-1.977)0.682
GlucoseNANA1.276 (1.109-1.468)0.001
PLTNANA0.999 (0.995-1.002)0.474
D-dimer (≥ 1.08 mg/L)88 (65.2)48 (32.4)3.901 (2.381-6.391)< 0.001
Infections44 (32.6)17 (11.5)3.726 (2.004-6.929)< 0.001
Malignant tumor61 (45.2)38 (25.7)2.386 (1.446-3.938)0.001
CarpriniNANA1.810 (1.511-2.168)< 0.001
Hemostatic drugs (days)NANA0.926 (0.782-1.096)0.371
Steroid61 (45.2)33 (22.3)2.873 (1.717-4.805)< 0.001
Operation timeNANA1.786 (1.486-2.148)< 0.001
Transfusion16 (11.9)5 (3.4)8.525 (3.207-22.664)< 0.001
IPC9 (6.7)62 (41.9)0.200 (0.109-0.366)< 0.001
Table 2 Multivariate analysis of the risk factors for deep vein thrombosis
Risk factors
β
Sx
P value
OR
95%CI
Lower limit
Upper limit
Age0.0620.017< 0.0011.0641.0291.100
D-dimer1.6810.375< 0.0015.3682.57511.190
Infections1.2680.4760.0083.5531.3979.039
Carprini0.5480.143< 0.0011.7311.3082.290
Steroid0.9630.3970.0152.6191.2035.706
Operation time0.3690.1430.0101.4461.0931.914
Transfusion1.3420.6570.0413.8281.05613.873
IPC-2.3700.486< 0.0010.0940.0360.242